Manus Rogan is a PhD chemist who began his career in product development at GlaxoSmithkline in the UK.  He completed an MBA at Trinity College Dublin in 1996 and joined Elan Corporation’s business development group shortly thereafter. For four years he was responsible for licensing Elan’s products and drug delivery technologies in Europe and Japan.

In 2001, Manus joined Elan’s corporate VC group in the US where he was involved in the sourcing, screening and management of investments in private and public biotechnology companies. In his 7 years at Elan, Manus concluded over twenty five investment and technology licensing transactions involving companies in the US, Europe and Japan.